Planet Labs PBC recently reported fourth-quarter and full-year results showing higher sales alongside wider losses, issued revenue guidance for the first quarter of fiscal 2027 and the full year, and filed a US$680.66 million shelf registration for an ESOP-related offering of 20,119,874 Class A shares. The company is also expanding its Berlin satellite manufacturing facility to double Pelican fleet production, supporting a growing backlog and government contracts while moving to redeem public warrants if its stock price meets specified conditions. We’ll now examine how Planet Labs’ Berlin manufacturing expansion shapes the existing investment narrative around government-focused satellite and data services.
This technology could replace computers: discover 22 stocks that are working to make quantum computing a reality.
Planet Labs PBC Investment Narrative Recap
To own Planet Labs, you have to believe its bet on higher value government and satellite services can eventually justify heavy spending and persistent losses. The Berlin expansion and Pelican ramp look supportive for near term revenue growth, but the widening net loss and rich sales multiple keep funding needs and dilution risk front and center, especially with the new US$680.66 million shelf and warrant redemption in play.
The most relevant update here is the fourth quarter and full year FY2026 result, which paired higher sales of US$307.73 million with a larger annual net loss of US$246.86 million. That combination, alongside guidance for FY2027 revenue of US$415 million to US$440 million, frames the Berlin build out as part of a bigger capacity push that could help address backlog and government demand but also amplifies the importance of disciplined capital deployment.
Yet beneath the growth story, investors should be aware that rising losses, potential dilution and contract concentration risk could all start to weigh heavily on…
Read the full narrative on Planet Labs PBC (it’s free!)
Planet Labs PBC’s narrative projects $409.3 million revenue and $29.2 million earnings by 2028. This requires 17.8% yearly revenue growth and an earnings increase of about $136 million from -$106.5 million today.
Uncover how Planet Labs PBC’s forecasts yield a $14.55 fair value, a 53% downside to its current price.
Exploring Other Perspectives
PL 1-Year Stock Price Chart
Some of the lowest ranked analysts were already assuming revenue of about US$400.5 million by 2028 and ongoing losses, so their more cautious view on contract dependence and regulation might shift again after Planet’s Berlin expansion and new guidance.
Explore 11 other fair value estimates on Planet Labs PBC – why the stock might be worth less than half the current price!
The Verdict Is Yours
Don’t just follow the ticker – dig into the data and build a conviction that’s truly your own.
Interested In Other Possibilities?
Early movers are already taking notice. See the stocks they’re targeting before they’ve flown the coop:
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We’ve created the ultimate portfolio companion for stock investors, and it’s free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com